Filana Therapeutics Inc

FLNANASDAQ · USD
0.47USD0.00 (+10.57%)
212

Filana Therapeutics Inc (FLNA) Covered Calls

Read more

Running FLNA covered calls helps you generate income from Filana Therapeutics Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best FLNA covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If FLNA stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling FLNA covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given FLNA covered call is worth writing.

Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

2028-01-214345.501179.070.051.55512.001190.701001.39-11.63+1.002371.50
2028-01-214344.00830.230.052.00362.00841.86708.02-11.63+1.002521.95
2028-01-214343.50713.950.052.20312.00725.58610.22-11.63+1.00812.15
2028-01-214343.00597.670.050.50262.00609.30512.43-11.63+0.775060.45
2028-01-214342.00365.120.050.60162.00376.74316.85-11.63+0.852540.55
2028-01-214341.50248.840.100.50117.00272.09228.83-23.26+0.821,0360.40
2028-01-214340.5016.280.051.0512.0027.9123.47-11.63+1.001291.00

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank—
  • Market cap (M$)24
  • 52 weeks high-86.38%
  • 52 weeks low11.90%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$6.50
    1282.98% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-05
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.87
  • EPS growth next 5 years15.11%

As of Nov 16, 2026